life sciences AI

Can Agentic AI Work on the Pharma Plant Floor? Pharma AI Startup Katalyze Raises $10.5M to Find Out

Katalyze AI has secured $10.5 million in seed funding to enhance its agentic AI operating system designed for pharmaceutical manufacturing and life sciences, aiming to connect disparate data systems within the sector, thereby improving operational efficiency and compliance.

Analytics and AI

Anthropic’s Ban Lift and Claude Science Launch Test the New Rules of AI Access

The Trump administration has lifted restrictions on Anthropic's Claude Fable 5 and Mythos 5 models, ending a weekslong export ban tied to cybersecurity concerns—though Mythos 5 remains restricted to approved US organizations. At the same time, Anthropic launched Claude Science, a domain-specific AI research workbench targeting life sciences and pharmaceutical users, signaling a broader shift toward specialized, governed enterprise AI access.